Evidence map›Paper›PMID 33537091›Full record

ReviewTheranostics2021

Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis.

Jingyi Li, Chunfen Mo, Yifan Guo, Bowen Zhang, Xiao Feng, Qiuyue Si, Xiaobo Wu, Zhe Zhao, Lixin Gong, Dan He and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Theranostics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Light-Activated Reactivity of Nitrones with Amino Acids and Proteins.Angewandte Chemie (International ed. in English) · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. The regulatory role of Pin1 in neuronal death.Neural regeneration research · 2023
    Review
  13. Article
  14. PIN1 and PIN4 inhibitionFrontiers in microbiology · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jingyi LiThe Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital, Chengdu, Sichuan, China.
Chunfen MoDepartment of Immunology, School of Basic Medical Sciences, Chengdu Medical College, Chengdu, China.
Yifan GuoSchool of Biological Sciences and Technology, Chengdu Medical College, Chengdu, China.
Bowen ZhangThe Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital, Chengdu, Sichuan, China.
Xiao FengSchool of Biological Sciences and Technology, Chengdu Medical College, Chengdu, China.
Qiuyue SiSchool of Biological Sciences and Technology, Chengdu Medical College, Chengdu, China.
Xiaobo WuSchool of Biological Sciences and Technology, Chengdu Medical College, Chengdu, China.
Zhe ZhaoSchool of Biological Sciences and Technology, Chengdu Medical College, Chengdu, China.
Lixin GongThe Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital, Chengdu, Sichuan, China.
Dan HeThe Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital, Chengdu, Sichuan, China.
Jichun ShaoThe Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital, Chengdu, Sichuan, China.
Chengdu Medical College · CNChina National Nuclear Corporation · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pin1 belongs to the peptidyl-prolyl cis-trans isomerases (PPIases) superfamily and catalyzes the cis-trans conversion of proline in target substrates to modulate diverse cellular functions including cell cycle progression, cell motility, and apoptosis. Dysregulation of Pin1 has wide-ranging influences on the fate of cells; therefore, it is closely related to the occurrence and development of various diseases. This review summarizes the current knowledge of Pin1 in disease pathogenesis.

Indexed as

ApoptosisCardiovascular DiseasesCell CycleCell MovementDiabetes Mellitus, Type 2Gene Expression RegulationHumansNeoplasm ProteinsNeoplasmsNeovascularization, PathologicNeurodegenerative DiseasesNIMA-Interacting Peptidylprolyl IsomeraseObesitySignal TransductionVirus DiseasesNeoplasm ProteinsNIMA-Interacting Peptidylprolyl IsomerasePIN1 protein, humanneurodegenerative diseasespathogenesis of diseasespeptidyl-prolyl cis-trans isomerasesPin1viral infection

Identifiers

PMID33537091
PMCPMC7847688
OpenAlexW3128528664

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.